drugset / Trial / NCT01489852

Estrogen Pretreatment Prior to GnRH Antagonist Protocol

NCT01489852

Phase 4 Completed 472 enrolled Gemer
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess whether estrogen pre-treatment can allow retrieval of 2 additional oocytes in GnRH antagonist protocol.

Timeline

Start
2006-12
Primary completion
2010-07
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator 17-beta estradiol Unknown 2 mg

Indications